Haemodynamic effects of diaspirin crosslinked haemoglobin (DCLHb) given before abdominal aortic aneurysm surgery

被引:18
作者
Garrioch, MA [1 ]
McClure, JH [1 ]
Wildsmith, JAW [1 ]
机构
[1] Royal Infirm, Dept Anaesthet, Edinburgh EH3 9YW, Midlothian, Scotland
关键词
surgery; vascular; blood; haemoglobin; DCLHb; cardiovascular system; effects; oxygen; transport;
D O I
10.1093/bja/83.5.702
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We studied 34 patients undergoing elective repair of an abdominal aortic aneurysm under combined general anaesthesia and epidural block to evaluate the acute effects of diaspirin crosslinked haemoglobin (DCLHb) 50, 100 and 200 mg kg(-1) i.v. Haemodynamic variables were measured continuously using pulmonary and radial artery catheters, and oxygen delivery and consumption were calculated at regular intervals. DCLHb was shown to be vasoactive, producing an increase in mean arterial pressure of approximately 25% with each dose, with small decreases in cardiac index and calculated oxygen delivery. These effects persisted beyond the end of infusion and provided a degree of cardiovascular stability during the operative procedure. The effects of DCLHb on oxygen consumption at these doses were minimal.
引用
收藏
页码:702 / 707
页数:6
相关论文
共 25 条
[1]   CLINICAL EXPERIENCE WITH HEMOGLOBIN-SALINE SOLUTIONS [J].
AMBERSON, WR ;
JENNINGS, JJ ;
RHODE, CM .
JOURNAL OF APPLIED PHYSIOLOGY, 1949, 1 (07) :469-489
[2]   Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb(TM)) for viral inactivation - Effect of crosslinking [J].
Azari, M ;
Catarello, J ;
Burhop, K ;
Camacho, T ;
Ebeling, A ;
Estep, T ;
Guzder, S ;
Krause, K ;
Marshall, T ;
Rohn, K ;
Sarajari, R ;
Boose, JA ;
Gauvin, G ;
Horner, R ;
Lu, B ;
Pearson, L ;
Vacante, D .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1997, 25 (06) :521-526
[3]   The use of diaspirin crosslinked hemoglobin (DCLHb) as an alternative to blood transfusion in cardiac surgery patients following cardiopulmonary bypass: A pivotal efficacy trial. [J].
Baron, JF ;
Berridge, J ;
Brichant, JF ;
Demeyere, R ;
Lamy, M ;
Larbuisson, R ;
Lehot, JJ ;
Parsloe, M ;
Sinclair, CJ ;
Vandermeersch, E .
ANESTHESIOLOGY, 1997, 87 (03) :A217-A217
[4]   THE APPLICATION OF REML IN CLINICAL-TRIALS [J].
BROWN, HK ;
KEMPTON, RA .
STATISTICS IN MEDICINE, 1994, 13 (16) :1601-1617
[5]   DIASPIRIN CROSS-LINKED HEMOGLOBIN RESUSCITATION OF HEMORRHAGE - COMPARISON OF A BLOOD SUBSTITUTE WITH HYPERTONIC SALINE AND ISOTONIC SALINE [J].
COHN, SM ;
FARRELL, TJ .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1995, 39 (02) :210-217
[6]  
ESTEP TN, 1989, BLOOD SUBSTITUTES, P129
[7]  
FARMER MC, 1995, ARTIFICIAL RED CELLS, P177
[8]  
GARRIOCH M, 1996, CRIT CARE MED, V24, pA39
[9]   Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin [J].
Gulati, A ;
Sharma, AC ;
Singh, G .
CRITICAL CARE MEDICINE, 1996, 24 (01) :137-147
[10]  
GULATI A, 1994, J LAB CLIN MED, V124, P125